HK1032012A1 - Oral liquid solution comprising the antidepressant mirtazapine - Google Patents

Oral liquid solution comprising the antidepressant mirtazapine

Info

Publication number
HK1032012A1
HK1032012A1 HK01102818A HK01102818A HK1032012A1 HK 1032012 A1 HK1032012 A1 HK 1032012A1 HK 01102818 A HK01102818 A HK 01102818A HK 01102818 A HK01102818 A HK 01102818A HK 1032012 A1 HK1032012 A1 HK 1032012A1
Authority
HK
Hong Kong
Prior art keywords
oral liquid
liquid solution
mirtazapine
antidepressant mirtazapine
antidepressant
Prior art date
Application number
HK01102818A
Other languages
English (en)
Inventor
Arnold Titus Philip Skrabanja
Roger Edward Tully
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of HK1032012A1 publication Critical patent/HK1032012A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
HK01102818A 1998-04-02 2001-04-20 Oral liquid solution comprising the antidepressant mirtazapine HK1032012A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98201037 1998-04-02
PCT/EP1999/002277 WO1999051237A1 (en) 1998-04-02 1999-03-29 Oral liquid antidepressant solution

Publications (1)

Publication Number Publication Date
HK1032012A1 true HK1032012A1 (en) 2001-07-06

Family

ID=8233550

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01102818A HK1032012A1 (en) 1998-04-02 2001-04-20 Oral liquid solution comprising the antidepressant mirtazapine

Country Status (12)

Country Link
US (2) US6040301A (de)
EP (1) EP1067934B1 (de)
AT (1) ATE254918T1 (de)
AU (1) AU747975B2 (de)
BR (1) BR9909357A (de)
CA (1) CA2326356C (de)
DE (1) DE69913116T2 (de)
DK (1) DK1067934T3 (de)
ES (1) ES2212550T3 (de)
HK (1) HK1032012A1 (de)
PT (1) PT1067934E (de)
WO (1) WO1999051237A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495534B2 (en) 2000-05-15 2002-12-17 Pharmacia & Upjohn Spa Stabilized aqueous suspensions for parenteral use
DE60224078T2 (de) * 2001-02-12 2008-12-04 N.V. Organon Verwendung von Mirtazapin zur Verbesserung der Behandlung von Menschen mit starken Depressionen, welche Träger des Gens für Apolipoprotein E4 sind.
US20030105082A1 (en) * 2001-12-03 2003-06-05 Murphy Greer Marechal Methods for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4
US6399310B1 (en) 2001-02-12 2002-06-04 Akzo Nobel N.V. Methods for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4
US20040156894A1 (en) * 2003-02-07 2004-08-12 Grother Leon Paul Use of edible acids in fast-dispersing pharmaceutical solid dosage forms
US7838029B1 (en) * 2003-07-31 2010-11-23 Watson Laboratories, Inc. Mirtazapine solid dosage forms
TW200538100A (en) * 2004-04-21 2005-12-01 Akzo Nobel Nv Mirtazapine salts
US20060039866A1 (en) * 2004-08-20 2006-02-23 Cypress Bioscience, Inc. Method for treating sleep-related breathing disorders
AU2005285040A1 (en) * 2004-09-14 2006-03-23 Molecular Therapeutics, Inc. D-methionine formulation with improved biopharmaceutical properties
WO2006052880A2 (en) * 2004-11-08 2006-05-18 New River Pharmaceuticals Inc. Synergistic effects of combined administration of mirtazapine and a stimulant compound
TW200631584A (en) * 2004-11-15 2006-09-16 Akzo Nobel Nv A medicament related to mirtazapine for the treatment of hot flush
US20060122127A1 (en) * 2004-11-17 2006-06-08 Cypress Bioscience, Inc. Methods for reducing the side effects associated with mirtzapine treatment
WO2008157094A1 (en) * 2007-06-13 2008-12-24 Cypress Bioscience, Inc. Improving the tolerability of mirtazapine and a second active by using them in combination
WO2011140358A2 (en) 2010-05-05 2011-11-10 Ener-G-Rotors, Inc. Fluid energy transfer device
US8714951B2 (en) * 2011-08-05 2014-05-06 Ener-G-Rotors, Inc. Fluid energy transfer device
DK3261645T3 (da) 2015-02-27 2021-06-07 Dechra Ltd Stimulering af appetit, håndtering af vægttab og behandling af anoreksi hos hunde og katte

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
ES2062310T3 (es) * 1989-12-06 1994-12-16 Akzo Nv Un procedimiento para fabricar un preparado farmaceutico acuoso estabilizado.
US5208261A (en) * 1989-12-06 1993-05-04 Akzo N.V. Stabilized solutions of psychotropic agents
IE63986B1 (en) * 1989-12-30 1995-06-28 Akzo Nv Pharmaceutical preparation for oral administration in fluid form
US5238699A (en) * 1991-11-27 1993-08-24 Kraft General Foods, Inc. Ready-to-eat, low/no-fat puddings and process

Also Published As

Publication number Publication date
WO1999051237A1 (en) 1999-10-14
EP1067934A1 (de) 2001-01-17
US6114324A (en) 2000-09-05
DE69913116T2 (de) 2004-06-03
AU3604899A (en) 1999-10-25
AU747975B2 (en) 2002-05-30
DE69913116D1 (de) 2004-01-08
CA2326356A1 (en) 1999-10-14
DK1067934T3 (da) 2004-03-29
CA2326356C (en) 2008-06-03
BR9909357A (pt) 2000-12-12
ES2212550T3 (es) 2004-07-16
US6040301A (en) 2000-03-21
PT1067934E (pt) 2004-03-31
ATE254918T1 (de) 2003-12-15
EP1067934B1 (de) 2003-11-26

Similar Documents

Publication Publication Date Title
HK1032012A1 (en) Oral liquid solution comprising the antidepressant mirtazapine
YU84703A (sh) Oralni rastvor aripiprazola
SG49049A1 (en) 5-(-2-Imidazolinylamino) benzimidazole derivatives their preparation and their use as alpha-2 adrenoceptor agonists
NZ234143A (en) Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
BR9917007A (pt) Moduladores de ccr5
AP2000001860A0 (en) Hypolipidemic benzothiazepine compounds.
MY128659A (en) Novel aminodicarboxylic acid derivatives having pharmaceutical properties
LU91281I2 (fr) Preotact-hormone parathyroïde
PL364598A1 (en) Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
WO2000002542A3 (de) Mittel mit antidepressiver wirkung, enthaltend pramipexol und ein weiteres antidepressivum
MX9605741A (es) Clorhidrato cristalino del (r)-(-)-2-{n-[4-(1,1-dioxido-3-oxo-2,3-dihidro-benzisotiazol-2-il)-butil ]-aminometil} cromano.
ATE249205T1 (de) Wässrige suspension zur nasalen verabreichung von loteprednol
MY124786A (en) Bis-arylsulfones
HRP20010969B1 (en) Novel piperazinylalkylthiopyrimidine derivatives,
PL350917A1 (en) C16 unsaturated fp-selective prostaglandins analogs
MX9805141A (es) Uso de inhibidores del intercambiador celular na+/h+ (nhe) para la preparacion de un farmaco para estimular la respiracion.
ES2108595A1 (es) Derivados de la 3(2h)-piridacinona y procedimiento para su preparacion.
BR0104358A (pt) Formulações de taxana tendo solubilidade aperfeiçoada
BR9812982A (pt) Agente anti-reumático
MXPA03008837A (es) Una composicion farmaceutica estable de pravastatina.
BR0114395A (pt) Composição farmacêutica para administração por suprimento via oral
MY139455A (en) Pharmaceutical composition comprising 5-methyl-2-2'(chloro-6'-fluoroanilino) phenylacetic acid
HU9600758D0 (en) Diclofenac composition of diminished gastrointestinal irritation and enhanced biological resorption
HUP0302255A2 (hu) Szulfonamidszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
PT1283042E (pt) Preparação líquida aquosa de pranoprofeno

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090329